Atsena Therapeutics has received EMA orphan designation for two gene [...]
ATSN-401, Atsena Therapeutics’ investigational gene therapy for Stargardt disease, has [...]
Atsena Therapeutics has received EMA orphan designation for two gene [...]
ATSN-401, Atsena Therapeutics’ investigational gene therapy for Stargardt disease, has [...]